XML 29 R18.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Stock-Based Compensation Plans | 6 Months Ended
--- | ---
Jun. 30, 2016
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Stock-Based Compensation Plans | (13) STOCK-BASED COMPENSATION PLANS Stock-Based Awards We have one active equity-based stock plan, our Amended and Restated 2005 Equity-Based Incentive Compensation Plan, which we refer to as the 2005 Plan. Under this plan, incentive and non-qualified stock options, SARs, and various other awards may be issued to non-employee directors and employees pursuant to decisions of the Compensation Committee, which is comprised of only non-employee, independent directors. In 2005, we began granting SARs which represent the right to receive a payment equal to the excess of the fair market value of shares of our common stock on the date the right is exercised over the value of the stock on the date of grant. All SARs granted under the 2005 Plan will be settled in shares of stock, vest over a three-year period and have a maximum term of five years from the date they are granted. In 2011, the Compensation Committee of the Board of Directors began granting restricted stock units under our equity-based stock compensation plans. These restricted stock units, which we refer to as restricted stock Equity Awards, vest over a three-year period. All awards granted have been issued at prevailing market prices at the time of grant and the vesting of these shares is based upon an employee’s continued employment with us, with the exception of employment termination due to death, disability or retirement. In first quarter 2014, the Compensation Committee began granting performance share unit (“PSU”) awards under our 2005 Plan. The number of shares to be issued is determined by our total shareholder return compared to the total shareholder return of a predetermined group of peer companies over the performance period. The grant date fair value of the PSU awards is determined using a Monte Carlo simulation and is recognized as stock-based compensation expense over the three-year performance period. The actual payout of shares granted depends on our total shareholder return compared to our peer companies and will be between zero and 150%. The Compensation Committee also grants restricted stock to certain employees and non-employee directors of the Board of Directors as part of their compensation. Upon grant of these restricted shares, which we refer to as restricted stock Liability Awards, the shares generally are placed in our deferred compensation plan and, upon vesting, employees are allowed to take withdrawals either in cash or in stock based on their distribution elections. Compensation expense is recognized over the vesting period, which is typically three years for employee grants and immediate vesting for non-employee directors. All restricted stock awards are issued at prevailing market prices at the time of the grant and vesting is based upon an employee’s continued employment with us, with the exception of employment termination due to death, disability or retirement. Prior to vesting, all restricted stock awards have the right to vote such shares and receive dividends thereon. These Liability Awards are classified as a liability and are remeasured at fair value each reporting period. This mark-to-market adjustment is reported as deferred compensation plan expense in the accompanying consolidated statements of operations. Total Stock-Based Compensation Expense Stock-based compensation represents amortization of restricted stock, PSUs and SARs expense. Unlike the other forms of stock-based compensation, the mark-to-market adjustment of the liability related to the vested restricted stock held in our deferred compensation plan is directly tied to the change in our stock price and not directly related to the functional expenses and therefore, is not allocated to the functional categories. The following table details the allocation of stock-based compensation to functional expense categories (in thousands):
|  | Three Months Ended June 30, |  |  |  | Six Months Ended June 30, |
| 2016 |  |  |  | 2015 |  |  |  | 2016 |  |  |  | 2015 |
Direct operating expense | $ | 696 |  |  | $ | 654 |  |  | $ | 1,284 |  |  | $ | 1,540 |
Brokered natural gas and marketing expense |  | 378 |  |  |  | 619 |  |  |  | 894 |  |  |  | 1,125 |
Exploration expense |  | 371 |  |  |  | 751 |  |  |  | 1,061 |  |  |  | 1,483 |
General and administrative expense |  | 15,443 |  |  |  | 15,953 |  |  |  | 26,556 |  |  |  | 27,033 |
Termination costs |  | ¾ |  |  |  | 434 |  |  |  | ¾ |  |  |  | 1,721 |
Total stock-based compensation | $ | 16,888 |  |  | $ | 18,411 |  |  | $ | 29,795 |  |  | $ | 32,902 |
Performance Share Unit Awards The following is a summary of our non-vested PSU awards outstanding at June 30, 2016:
|  | Number of Units |  |  | Weighted Average Grant Date Fair Value |
Outstanding at December 31, 2015 |  |  | 262,124 |  |  | $ | 64.77 |
Units granted (a) |  |  | 413,959 |  |  |  | 36.64 |
Units vested |  |  | (113,041 | ) |  |  | 52.88 |
Units forfeited |  |  | (42,603 | ) |  |  | 46.09 |
Outstanding at June 30, 2016 |  |  | 520,439 |  |  | $ | 46.51 |
(a) Amounts granted reflect the number of performance units granted; however, the actual payout of shares will be between zero percent and 150% of the performance units granted depending on the total shareholder return ranking compared to the peer companies at the end of the three-year performance period. The following assumptions were used to estimate the fair value of PSUs granted during first six months 2016 and 2015:
|  | Six Months Ended June 30, |
| 2016 |  |  |  | 2015 |
Risk-free interest rate |  | 0.94 | % |  |  | 1.0 | %
Expected annual volatility |  | 49 | % |  |  | 33 | %
Weighted average grant date fair value per unit | $ | 36.64 |  |  | $ | 56.78 |
We recorded PSU compensation expense of $5.6 million in first six months 2016 compared to $4.1 million in the same period of 2015. Restricted Stock Awards Equity Awards In first six months 2016, we granted 940,000 restricted stock Equity Awards to employees at an average grant price of $28.18 compared to 583,000 restricted stock Equity Awards granted to employees at an average grant price of $52.45 in first six months 2015. These awards generally vest over a three-year period. We recorded compensation expense for these Equity Awards of $11.5 million in first six months 2016 compared to $14.0 million in the same period of 2015. Equity Awards are not issued to employees until they are vested. Employees do not have the option to receive cash. Liability Awards In first six months 2016, we granted 456,000 shares of restricted stock Liability Awards as compensation to employees at an average price of $35.70 with vesting over a three-year period and 52,000 shares were granted to non-employee directors at an average price of $38.73 with immediate vesting. In first six months 2015, we granted 294,000 shares of Liability Awards as compensation to employees at an average price of $56.20 with vesting over a three-year period and 39,000 shares were granted to non-employee directors at an average price of $58.35 with immediate vesting. We recorded compensation expense for Liability Awards of $11.3 million in first six months 2016 compared to $11.7 million in the same period of 2015. Substantially all of these awards are held in our deferred compensation plan, are classified as a liability and are remeasured at fair value at the end of each reporting period. This mark-to-market adjustment is reported as deferred compensation expense in our consolidated statements of operations (see additional discussion below). The following is a summary of the status of our non-vested restricted stock outstanding at June 30, 2016:
|  | Equity Awards |  |  | Liability Awards |
|  | Shares |  |  | Weighted Average Grant Date Fair Value |  |  | Shares |  |  | Weighted Average Grant Date Fair Value |
Outstanding at December 31, 2015 |  |  | 436,764 |  |  | $ | 59.74 |  |  |  | 308,737 |  |  | $ | 65.80 |
Granted |  |  | 940,491 |  |  |  | 28.18 |  |  |  | 508,206 |  |  |  | 36.01 |
Vested |  |  | (255,270 | ) |  |  | 45.79 |  |  |  | (214,406 | ) |  |  | 52.91 |
Forfeited |  |  | (106,120 | ) |  |  | 43.45 |  |  |  | (49,519 | ) |  |  | 40.33 |
Outstanding at June 30, 2016 |  |  | 1,015,865 |  |  | $ | 35.73 |  |  |  | 553,018 |  |  | $ | 45.70 |
Stock Appreciation Right Awards There were 1.0 million SARs outstanding at June 30, 2016. Information with respect to SARs activity in the six months ended June 30, 2016 is summarized below:
|  | Shares |  |  | Weighted Average Exercise Price |
Outstanding at December 31, 2015 |  |  | 1,510,977 |  |  | $ | 63.73 |
Exercised |  |  | — |  |  |  | — |
Expired/forfeited |  |  | (507,377 | ) |  |  | 53.16 |
Outstanding at June 30, 2016 |  |  | 1,003,600 |  |  | $ | 69.08 |
Deferred Compensation Plan Our deferred compensation plan gives non-employee directors and officers the ability to defer all or a portion of their salaries, bonuses or director fees and invest in Range common stock or make other investments at the individual’s discretion. Range provides a partial matching contribution to officers which vests over three years. The assets of the plan are held in a grantor trust, which we refer to as the Rabbi Trust, and are therefore available to satisfy the claims of our general creditors in the event of bankruptcy or insolvency. Our stock held in the Rabbi Trust is treated as a liability award as employees are allowed to take withdrawals from the Rabbi Trust either in cash or in Range stock. The liability for the vested portion of the stock held in the Rabbi Trust is reflected as deferred compensation liability in the accompanying consolidated balance sheets and is adjusted to fair value each reporting period by a charge or credit to deferred compensation plan expense on our consolidated statements of operations. The assets of the Rabbi Trust, other than our common stock, are invested in marketable securities and reported at their market value as other assets in the accompanying consolidated balance sheets. The deferred compensation liability reflects the vested market value of the marketable securities and Range stock held in the Rabbi Trust. Changes in the market value of the marketable securities and changes in the fair value of the deferred compensation plan liability are charged or credited to deferred compensation plan expense each quarter. We recorded mark-to-market loss of $25.7 million in second quarter 2016 compared to mark-to-market gain of $7.3 million in second quarter 2015. We recorded a mark-to-market loss of $41.8 million in first six months 2016 compared to a gain of $12.9 million in first six months 2015. The Rabbi Trust held 2.8 million shares (2.3 million of which were vested) of Range stock at June 30, 2016 compared to 2.8 million shares (2.5 million of which were vested) at December 31, 2015.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=65895303&loc=d3e17540-113929 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration